Tweet
New plan to combat ?avian flu? .. And fears of the virus mutating
Books Metwally Salem, Washington, Reuters 27 / 2 / 2010
Abaza
Has the state bodies concerned to prepare a new plan to combat bird flu, the face of increasing numbers of human cases of the disease, amid renewed fears of a mutation of the virus.
Dr. Hamed Samaha, President of the General Authority for Veterinary Services, said he decided to stop vaccinating birds in rural education, having emphasized the scientific reports and veterinary ineffectual to resist the poultry disease, pointing out the importance of educating citizens the right rules of prevention.
He told Al-tolerance ?Egyptian today? The new plan depends on raising the efficiency of veterinary services, to provide the service at the highest level and to provide for appropriate financial and human, for the development of veterinary services in the governorates and the General Authority for Veterinary Services.
He pointed out that activation of ministerial decisions on conditions to be met by bio-security in poultry farms, and its application to ?ground? rather than ink on paper, calling for the participation of local bodies to support efforts to control avian flu in the future risks of the possibility of mutation of the virus , and ?is what we fear happening now?.
The head of the veterinary that new rules for bio-safety conditions in poultry farms will be approved during the next few days, including the abolition of farm licenses who violate these rules.
Globally, U.S. researchers have discovered that a single dose of a drug test for influenza protects mice from avian flu, more of the drug of choice ?Tamiflu?, and can protect against HIV infection, and Tests on the drug ?NCS 8958? or ?to Aninamifir?, made by Company ?Dajicy Sankyo? America to a single dose inhalation gave better results than ?Tamiflu? in maintaining the life of mice when infected with a lethal dose in the usual.
It covers the new report published in the journal Public Library of Science and one of dozens of studies under way on a new set of flu drugs developed by a variety of companies.
Books Metwally Salem, Washington, Reuters 27 / 2 / 2010
Abaza
Has the state bodies concerned to prepare a new plan to combat bird flu, the face of increasing numbers of human cases of the disease, amid renewed fears of a mutation of the virus.
Dr. Hamed Samaha, President of the General Authority for Veterinary Services, said he decided to stop vaccinating birds in rural education, having emphasized the scientific reports and veterinary ineffectual to resist the poultry disease, pointing out the importance of educating citizens the right rules of prevention.
He told Al-tolerance ?Egyptian today? The new plan depends on raising the efficiency of veterinary services, to provide the service at the highest level and to provide for appropriate financial and human, for the development of veterinary services in the governorates and the General Authority for Veterinary Services.
He pointed out that activation of ministerial decisions on conditions to be met by bio-security in poultry farms, and its application to ?ground? rather than ink on paper, calling for the participation of local bodies to support efforts to control avian flu in the future risks of the possibility of mutation of the virus , and ?is what we fear happening now?.
The head of the veterinary that new rules for bio-safety conditions in poultry farms will be approved during the next few days, including the abolition of farm licenses who violate these rules.
Globally, U.S. researchers have discovered that a single dose of a drug test for influenza protects mice from avian flu, more of the drug of choice ?Tamiflu?, and can protect against HIV infection, and Tests on the drug ?NCS 8958? or ?to Aninamifir?, made by Company ?Dajicy Sankyo? America to a single dose inhalation gave better results than ?Tamiflu? in maintaining the life of mice when infected with a lethal dose in the usual.
It covers the new report published in the journal Public Library of Science and one of dozens of studies under way on a new set of flu drugs developed by a variety of companies.